Product logins

Find logins to all Clarivate products below.


Ruth Howells

Senior Director, Health Technology Assessment

Ruth is Head of Health Technology Assessment (HTA) at Clarivate. Ruth has overall responsibility for our Global HTA services and has been extensively involved in the development and strategic direction of HTAs, contributing in-depth knowledge of procedural processes. ​

Ruth oversees our global HTA services from early scientific advice, through local submissions and global HTA programs to post-submission support. With extensive experience of managing HTA submissions globally, Ruth works closely with our clients and in-house team, advising manufacturers on their role and requirements, and significantly contributes to the development and communication of the HTA strategy and evidence generation planning from an early stage.

Prior to joining Clarivate, Ruth worked for the National Institute for Health and Care Excellence (NICE) and has over 20 years’ experience in health outcomes research. Ruth has an MSc in Health Economics from the University of York and her experience in health outcomes research covers a wide range of therapeutic areas including, oncology (cervical cancer, head and neck cancer, colorectal cancer, breast cancer), respiratory disease, cardiology, nephrology, gynecology, gastroenterology and dermatology. Ruth is an expert in HTA for rare diseases and in innovative therapies such as cell and gene therapies.


arrow_forward
Get in touch with Ruth

Latest news

News March 30, 2026
Clarivate Selected by University of Texas at Dallas Libraries to Provide Alma Specto

Alma Specto, an AI-native digital collection and exhibition platform offers UT Dallas Libraries a scalable, flexible and future-ready solution, expanding the reach of its Special Collections to new audiences London,…

News March 26, 2026
Clarivate Reveals the AI50 – the Organizations Leading Artificial Intelligence Invention

London, U.K. March, 26, 2026. Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the Clarivate AI50, a new data-driven benchmark of organizations demonstrating exceptional leadership in…

News March 25, 2026
Annual Report to Identify 189 Global Engineering Fronts Released by Clarivate, the Chinese Academy of Engineering and the Higher Education Press of China

A comprehensive outlook on engineering innovations London, U.K. March 25, 2026. Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, the Chinese Academy of Engineering (CAE) and the…

Related resources

How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
Biopharma Biotech Commercialization Consulting Resource Center FDA HMO Insurance Launch Managed care Market Access North America Payer Pharma pricing Route of administration U.S.
Managing uncertainty for medicine in Washington Managing uncertainty for medicine in Washington
Blog May 15, 2025
Managing uncertainty for medicine in Washington
Clinical research Early drug development research Market Access Pharma Portfolio strategy Research Research and development Research commercialization Research evaluation and management
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Market Access Pharma Portfolio strategy Regulatory Research commercialization
Five Medtech Trends to Watch in 2025 Five Medtech Trends to Watch in 2025
Blog February 11, 2025
Five Medtech Trends to Watch in 2025
Medical technology Medtech Medtech Resource Center